D014015OrganizationsProceduresN02.278.065.900160.998712Tissue Bankscmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.2577940.2577941research area of0.1633030.03057837subject area forMDBradleyWaradyBradley A. Warady0.000000000000000.0000000000000063Warady, BradleyDirector, Division of Pediatric Nephrology 8644154Luger AM, Bryan CF, O'Brien BJ, Pierce GE, Shield CF, Warady BA, Aeder MI, Landreneau MD, Nelson PW, Ross GTransplantation proceedingsLuger AM, Bryan CF, O'Brien BJ, Pierce GE, Shield CF, Warady BA, Aeder MI, Landreneau MD, Nelson PW, Ross G. Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization? Transplant Proc. 1996 Feb; 28(1):157-9.Transplant Proc1996-02-01T00:00:001996Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization?8644187Bryan CF, Shield CF, Warady BA, Aeder MI, Landreneau MD, Luger AM, Nelson PW, Pierce GE, Ross GTransplantation proceedingsBryan CF, Shield CF, Warady BA, Aeder MI, Landreneau MD, Luger AM, Nelson PW, Pierce GE, Ross G. Allocation of kidneys to Afro-American patients is proportional to wait-list composition. Transplant Proc. 1996 Feb; 28(1):219-20.Transplant Proc1996-02-01T00:00:001996Allocation of kidneys to Afro-American patients is proportional to wait-list composition.10083085Bryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ERTransplantation proceedingsBryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ER. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):225-7.Transplant Proc1999-02-01T00:00:001999Influence of an historically positive crossmatch on cadaveric renal transplantation.10084756Osorio AV, Sullivan EK, Alexander SR, Bryan CF, Shield CF, Warady BAPediatric transplantationOsorio AV, Sullivan EK, Alexander SR, Bryan CF, Shield CF, Warady BA. ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB). Pediatr Transplant. 1998 Feb; 2(1):26-9.Pediatr Transplant1998-02-01T00:00:001998ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).23149009Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GTClinical therapeuticsAbdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT. Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group. Clin Ther. 2012 Nov; 34(11):S11-24.Clin Ther2012-11-01T00:00:002012Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.PediatricsClinicalChildren's Mercy Kansas Citytrue1Director, Division of Pediatric Nephrology Director, Division of Pediatric Nephrology